Prevalence of Barrett's esophagus in a Southern European country: a multicenter study
Autores da FMUP
Participantes de fora da FMUP
- de Sá, IM
- Leal, C
- Silva, J
- Falcao, D
- Felix, C
- Nascimento, C
- Carvalho, PB
- Vasconcelos, H
- Pedroto, I
- Chagas, C
- Cravo, M
- Cotter, J
- Sharma, P
Unidades de investigação
Abstract
Background Identification of Barrett's esophagus (BE) with the treatment of dysplasia is essential to prevent esophageal adenocarcinoma (EAC). Moreover, determination of BE prevalence is important to define subsequent management strategies. However, precise estimates on BE prevalence from several European countries are lacking. We aimed to determine BE prevalence in a Southern European country. Methods A cross-sectional, multicenter study from November 2019 to February 2020 was performed defining BE as a columnar extent in the distal esophagus greater than or equal to 1 cm with intestinal metaplasia. Results A total of 1550 individuals, 51% male with a mean age of 62 (SD = 15) years undergoing upper endoscopy were included. The overall BE prevalence was 1.29% (95% confidence interval: 0.73-1.85); significantly higher in men [2.05% (1.06-3.04)] vs. women [0.53% (0.01-1.04)]. Of the 20 BE patients, eight were newly diagnosed and 12 were under surveillance. The median extent was C3 (min 0; max 16) M4.5 (min 2; max 16). One patient each had EAC (0.06%) and high-grade dysplasia (0.06%) at the time of endoscopy. There was no difference in prevalence between geographical regions, centers, use of sedation or experience of endoscopists. Considering all reports, 93% used standardized terminology, 23% accurate photodocumentation and 69% photodocumented the esophagogastric junction (EGJ). Furthermore, 80% used Prague classification, 55% Seattle protocol, 60% distance to the squamocolumnar junction, 75% to the EGJ and 40% to the hiatal pinch. When considering only reports with EGJ photodocumentation or Prague classification, the prevalence was 1.78% (0.91-2.64) or 1.03% (0.53-1.53). Conclusion We report for the first time BE prevalence in Southern Europe and report a low overall prevalence in an unselected population. Future studies need to determine progression rates and how to improve quality metrics. Copyright (C) 2021 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Dados da publicação
- ISSN/ISSNe:
- 0954-691X, 1473-5687
- Tipo:
- Article
- Páginas:
- 939-943
- Link para outro recurso:
- www.scopus.com
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY Lippincott Williams and Wilkins Ltd.
Citações Recebidas na Web of Science: 2
Citações Recebidas na Scopus: 6
Documentos
- Não há documentos
Filiações
Keywords
- Barrett's esophagus; prevalence; quality; South Europe
Proyectos asociados
Individualized gastric adenocarcinoma early diagnosis and improved patients survival: from liquid biopsies to a comprehensive management approach. (IMAGE)
Investigador Principal: Mário Jorge Dinis Ribeiro
Estudo Clínico Académico (IMAGE) . AgênciaD&C . 2021
Effectiveness of endoscopic resection of colonic lesions > 20mm
Investigador Principal: Mário Jorge Dinis Ribeiro
Estudo Clínico Académico (Colonic lesions) . 2020
Citar a publicação
de Sá IM,Leal C,Silva J,Falcao D,Felix C,Nascimento C,Carvalho PB,Vasconcelos H,Pedroto I,Chagas C,Cravo M,Cotter J,Sharma P,Dinis M. Prevalence of Barrett's esophagus in a Southern European country: a multicenter study. Eur. J. Gastroenterol. Hepatol. 2021. 33. (1):p. 939-943. IF:2,586. (4).